SCHEMBL22282003

SCHEMBL22282003

Clc1nc(N[C@@H]2CCc3ccccc32)c2cn[nH]c2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 2/20 0.47
TRPV1 Q8NER1 1/20 0.44
FADS1 O60427 1/20 0.44
IGF1R P08069 1/20 0.42
PLK4 O00444 1/20 0.42
PAK4 O96013 1/20 0.42
CDK1 P06493 1/20 0.41
EGFR P00533 1/20 0.41
PDPK1 O15530 1/20 0.40
P2RX7 Q99572 2/20 0.40
AURKA O14965 1/20 0.40
RPS6KB1 P23443 1/20 0.40
PDE2A O00408 1/20 0.39
GLP1R P43220 1/20 0.39
NSD2 O96028 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19010748 0.82 FADS1 (0.45) GBA1FADS1PAK4CDK1EGFR
SCHEMBL1798451 0.77 FADS1 (0.45) GBA1FADS1IGF1RCDK1EGFR
SCHEMBL3754341 0.75 HPGDS (0.53) PLK4PAK4PDE2AKMT2A
SCHEMBL20511289 0.74 FADS1 (0.55) FADS1IGF1RPDPK1P2RX7NSD2
SCHEMBL782435 0.74 FADS1 (0.55) FADS1IGF1RPDPK1P2RX7NSD2
SCHEMBL22282069 0.72 HPGDS (0.61) PLK4PAK4PDE2AKDM4EMEN1
SCHEMBL29705692 0.72 HPGDS (0.61) PLK4PAK4PDE2AKDM4EMEN1
SCHEMBL20569405 0.72 GBA1 (0.53) GBA1P2RX7AURKARPS6KB1GLP1R
SCHEMBL22281549 0.71 HPGDS (0.60) PLK4PAK4PDE2AKDM4EMEN1
SCHEMBL30468603 0.70 FADS1 (0.45) GBA1FADS1IGF1RCDK1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020151707-A1 NOVEL SMALL MOLECULE CD73 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF 江苏恒瑞医药股份有限公司 2020-07-30 WO disclosed